Business ❯ Healthcare

Pharmaceuticals

Drug Development Clinical Trials Market Competition Weight Loss Drugs Oncology Biotechnology Drug Pricing Manufacturing Acquisitions Market Trends

Pfizer's 7% Dividend Faces Real Risk After $14.6 Billion in Payouts

Stressed cash coverage and looming patent expirations could force a cut if new revenue does not arrive.

Glenmark Settles for $29.6 Million Over Alleged Generic Drug Price Conspiracy

Abbott Beats Q2 Estimates and Raises 2026 Profit Outlook

Johnson & Johnson Beats Q2 Estimates and Lifts Full‑Year Outlook

Chai Discovery Raises $400 Million to Scale AI Drug Design

Agenus Secures $85M Now and Up to $340M Total to Back a Registrational Colon Cancer Trial

Virax Biolabs Signs Exclusive ImmuneSelect Supply Deal With Fosun Diagnostics

Healthcare ETFs Force a Choice Between Low Cost and Higher Growth

Viking Therapeutics Rallies as Weight‑Loss Program Moves Toward Late‑Stage Testing

House Select Committee Opens National-Security Inquiries Into Merck and AbbVie China Trials

AST SpaceMobile Confirms August Falcon 9 Launch as Satellite Production Accelerates

Zymeworks to Buy Theravance for $929 Million

Johnson & Johnson Hits Record After Analyst Upgrade and Strong Drug Prescriptions

Florida Attorney General Issues CID to CVS in Probe of PBM and Pharmacy Practices

UK Clears Oral Wegovy and Foundation Pledges Europe Research Cash

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

Sanofi Names Paulo Fontoura Global Head of R&D Pharma

Eli Lilly's GLP‑1 Surge Leaves Pfizer as the High‑Yield Option

Securities Class Action Filed Against Zoetis Over Companion‑Animal Sales Decline